Heartburn Medication Kidney Failure and Chronic Kidney Disease Risk
As our lawyers at Saiontz & Kirk, P.A. continue to review potential Nexium lawsuits, Prilosec lawsuits and other claims involving kidney problems associated with a popular class of heartburn medications, a study released this week provides further evidence users may face an increased risk of chronic kidney disease and kidney failure.
Diagnosed with Kidney Failure, Kidney Disease or Kidney Injury?
It is becoming increasingly clear that the makers of Nexium, Prilosec, Dexilant, Protonix, Prevacid, AcipHex and other proton pump inhibitors (PPI) have failed to adequately research the side effects of their medications or warn about the potential kidney risks.
In a study published by the Journal of the American Society of Nephrology on April 14, researchers from St. Louis examined databases from the Department of Veteran Affairs to evaluate kidney outcomes among more than 170,000 users of PPI drugs.
The incidents of chronic kidney disease and end stage kidney failure among users of Nexium, Prilosec and other PPI medications was compared to the risk among individuals who received a different type of heartburn medication, known as H2 blockers, which include Zantac, Pepcid, Tagamet and others.
Among the findings, users of Nexium, Prilosec and other PPI-based heartburn drugs had a:
- 28% increased risk of Chronic Kidney Disease (CKD);
- 96% increased chance of end-stage renal failure, or kidney failure, within five years of starting to use the drugs;
- Greater kidney damage risk the longer Nexium or other heartburn drugs are used;
- 15% of PPI users will develop chronic kidney disease within five years.
This research adds to the findings of two prior studies on the link between Nexium and kidney problems, which were published by the medical journal CMAJ Open in April 2015 and JAMA Internal Medicine January 2016.
Heartburn Drug Lawsuits
While most consumers are just starting to learn about the kidney risks from Nexium, Prilosec and other heartburn drugs, manufacturers knew or should have known about the potential side effects for years.
As a result of the apparent decision to place their desire for profits before consumer safety, financial compensation may be available for individuals who have suffered any of the following problems:
- Acute Interstitial Nephritis
- Acute Kidney Injury
- Chronic Kidney Disease
- End Stage Renal Disease or Kidney Failure
- Dialysis Treatment
- Kidney Transplant
- Wrongful Death
All cases are reviewed by the heartburn medication lawyers at Saiontz & Kirk, P.A. on a contingency fee basis, which means that there are never any out of pocket costs to hire our law firm and we only receive an attorney fee or expense reimbursement if we are successful obtaining a recovery.